Fluorescence Anisotropy Insulin Detection Microfluidics

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for measuring insulin release from pancreatic islets, such as enzyme-linked immunosorbent assays (ELISAs), are time-consuming, labor-intensive, and require complex wash steps, limiting their ability to detect rapid insulin dynamics and synchronize insulin oscillations effectively.

Innovation Solution

The development of fluorescence anisotropy-based homogeneous assays using SeTau-647 as a fluorescent label and an actively-controlled perfusion system in microfluidic devices, allowing for online monitoring of insulin release with improved temporal resolution and signal-to-noise ratio.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If heterogeneous antibody-based assays (ELISA) are used for insulin measurement, then high sensitivity is achieved, but processing time increases and online measurement becomes difficult

Engineering Contradiction:
Improveinsulin measurement sensitivityVSAvoidprocessing time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent replaces the mechanical/wash-based ELISA system with a homogeneous fluorescence anisotropy-based assay system. This substitution eliminates the need for physical wash steps and separation processes, enabling continuous online measurement while maintaining high sensitivity through optical detection mechanisms.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The homogeneous assay enables continuous measurement without interruption for wash steps. The fluorescence anisotropy signal can be monitored continuously as insulin is secreted, providing uninterrupted data streams that capture dynamic insulin release patterns in real-time.

Inventive Principle:
Principle #20Continuity of useful action

2Temperature

If microfluidic channels with dimensions less than 10 μm in depth are used, then electric current and Joule heating are reduced to acceptable levels, but channel fabrication becomes more arduous and clogging risk increases

Engineering Contradiction:
ImproveJoule heating controlVSAvoidchannel fabrication difficulty
Core Design Contradiction:
TemperatureVSEase of manufacture

Solution Approach 1:

The patent changes the detection parameter from electrical current-based to optical fluorescence anisotropy-based measurement. This parameter change allows the use of larger channel dimensions that are easier to fabricate and less prone to clogging, while still achieving the necessary measurement sensitivity through optical rather than electrical detection.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If fluorescence anisotropy immunoassays are used for online insulin detection, then homogeneous measurement without wash steps is achieved, but signal-to-noise ratio and dynamic range are limited

Engineering Contradiction:
Improveonline measurement capabilityVSAvoidsignal-to-noise ratio
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The patent changes the fluorescent label parameters by using SeTau-647 with specific photophysical properties (quantum yield, Stokes shift, lifetime) that optimize fluorescence anisotropy signal generation. This parameter optimization enhances the signal-to-noise ratio and extends the dynamic range while maintaining the homogeneous assay format.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent employs composite labeling strategies combining SeTau-647 fluorophore with insulin molecules, creating a conjugate that exhibits enhanced fluorescence anisotropy properties. This composite approach amplifies the signal while maintaining the homogeneous measurement capability.

Inventive Principle:
Principle #40Composite materials

4Quantity of substance

If conventional insulin measurement methods are used, then insulin release can be detected, but rapid insulin dynamics and synchronization cannot be measured effectively

Engineering Contradiction:
Improveinsulin detection capabilityVSAvoidtemporal resolution
Core Design Contradiction:
Quantity of substanceVSSpeed

Solution Approach 1:

The continuous fluorescence anisotropy measurement enables uninterrupted monitoring of insulin secretion dynamics. The system continuously captures insulin release events without the temporal gaps introduced by wash steps, achieving the temporal resolution necessary to detect rapid insulin dynamics and synchronization phenomena.

Inventive Principle:
Principle #20Continuity of useful action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

These assays enable sensitive and robust detection of insulin release from single or grouped islets, providing a 45% boost in signal-to-noise and dynamic range, and achieving thrice the temporal resolution of previous methods, facilitating the measurement of rapid insulin secretion dynamics and islet synchronization.

Implementation Method 1

Fluorescence anisotropy is an all-optical, quantitative method for analysis of the degree of rotational depolarization of a fluorophore

Methodology Applied
Scientific EffectFluorescence anisotropy: Anisotropy

Implementation Method 2

analysis of the degree of rotational depolarization of a fluorophore

Methodology Applied
Scientific EffectRotational depolarization: Polarisation

Implementation Method 3

contacting the first stream with an anti-insulin antibody and a labeled insulin to produce a second stream that includes the target insulin, an amount of an antibody-bound (B) labeled insulin, and an amount of free (F) labeled insulin

Methodology Applied
Scientific EffectAntibody-antigen binding: Chemical Bonding

Data Source

PatentUS20210341496A1Systems and Methods for Detecting or Monitoring Insulin
Publication Date: 2021.11.04 FLORIDA STATE UNIV RES FOUND INC
  • US20210341496A1 patent drawing
  • US20210341496A1 patent drawing
  • US20210341496A1 patent drawing

AI summary

Methods and systems for insulin detection. The methods may include contacting one or more islets with glucose to produce a first stream that is then contacted with an anti-insulin antibody and a labeled insulin to produce a second stream. The second stream may be analyzed to determine a ratio of antibody-bound (B) labeled insulin to free (F) labeled insulin in the second stream, wherein the ratio of B:F is inversely related to a concentration of target insulin.